BIOCORP and NOVO NORDISK sign global partnership within diabetes on digital health

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, today announces an agreement with Novo Nordisk, a world leader in diabetes care, for the development and distribution (pending successful development) of a Mallya smart add-on device for the Novo Nordisk FlexTouch pen used by people with diabetes.

YOU ARE

PROFESSIONAL?

To subscribe, please contact :

Ageas, Aprep Diffusion, AXA Thema, Cardif, Alpheys, Generali Patrimoine, Intencial Patrimoine, Nortia, Primonial, Sélection 1818, Spirica, Swisslife, UAF Life Patrimoine, Vie Plus

YOU ARE

PRIVATE INVESTOR ?

You can subscribe to INOCAP Gestion funds:

– Through your usual financial intermediary (your bank, for example), indicating the name of the fund, its ISIN code, the transaction you wish to carry out (subscription), the amount of this transaction (or the number of units).

– Through an independent wealth management advisor, who will tell you how to subscribe.

BEFORE SUBSCRIBING, WE INVITE YOU TO READ THE FUND’S PROSPECTUS AND DICI at MORE INFORMATION contact@inocapgestion.com / tel. +33 (0)1 42 99 34 60